Kerri Nottage, MD

    Kerri Nottage, MD, MPH

    Assistant Member, St. Jude Faculty

    Departments

    Hematology

    Contact Information

    Kerri Nottage, MD, MPH
    Hematology
    MS 800, Room R5013
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: kerri.nottage@stjude.org
    Phone: (901) 595-6216
    FAX: (901) 595-2952

    Education

    BS – University of Rhode Island, Kingston, Rhode Island
    MPH (Epidemiology Concentration) - University of Memphis, Memphis, TN
    MD – Brown University Medical School, Providence, Rhode Island
    Internship/Residency (Internal Medicine and Pediatrics) – Rhode Island Hospital/Hasbro Children’s Hospital
    Fellowship (Pediatric Hematology/Oncology) - St. Jude Children’s Research Hospital


    Research Interests


    Selected Publications

    Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC. From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 93(28):e215, 2014.

    Nottage KA, Ware RE, Winter B, Smeltzer M, Wang WC, Hankins JS, Dertinger SD, Shulkin B, Aygun B. Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. Eur J Haematol 93(5):377-383, 2014.

    Sheehan VA, Crosby JR, Sabo A, Mortier NA, Howard TA, Muzny DM, Dugan-Perez S, Aygun B, Nottage KA, Boerwinkle E, Gibbs RA, Ware RE, Flanagan JM. Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia. PLoS One 9(10):e110740, 2014.

    Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, Lanctot JQ, Chemaitilly W, Laver JH, Srivastava DK, Robison LL, Hudson MM, Ness KK. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer 120(17):2742-2750, 2014.

    Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, Lanctot JQ, Ojha RP, Nottage KA, Wilson CL, Li Z, Robison LL, Hudson MM. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 61(7):1270-1276, 2014.

    Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort. Br J Haematol 165(3):364-374, 2014.

    Nottage KA, Hankins JS, Smeltzer M, Mzayek F, Wang WC, Aygun B, Gurney JG. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PLoS One 8(8):e72077, 2013.

    Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma 54(8):1719-23, 2013. PMID: 23163568

    Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309(22):2371-81, 2013.

    Gawade PL, Ness KK, Sharma S, Li Z, Srivastava DK, Spunt SL, Nottage K, Krasin MJ, Hudson MM, Kaste SC. Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv Dec;6(4):388-97, 2012. PMID: 22956305

    Nottage K, McFarlane J, Krasin MJ, Li C, Srivastava D, Robison LL, Hudson MM. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 30(20):2552-8, 2012. PMID: 22665546

    Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows AT, Srivastava DK, Robison LL, Armstrong GT. Long-Term Risk for Secondary Leukemia after Treatment for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Blood 117(23):6315-8, 2011. PMID: 21498675

    Jeng MR, Naidu PE, Rieman MD, Rodriguez-Galindo C, Nottage KA, Thornton DT, Li CS, Wang WC. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Pediatr Blood Cancer 45(2):170-5, 2005. PMID: 15593082

    Last update: January 2015